Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer We reported previously that the ...
Validation of correlation of RECIST changes with survival in metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results